{"id":63736,"title":"Ibrutinib approved for mantle cell lymphoma.","abstract":"The U.S. Food and Drug Administration (FDA) has approved the targeted therapy ibrutinib (Imbruvica; Johnson & Johnson and Pharmacyclics) for treating patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.","date":"2014-01-09","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24402946","annotations":[{"name":"Targeted therapy","weight":0.344348,"wikipedia_article":"http://en.wikipedia.org/wiki/Targeted_therapy"},{"name":"Food and Drug Administration","weight":0.314511,"wikipedia_article":"http://en.wikipedia.org/wiki/Food_and_Drug_Administration"},{"name":"Cell (biology)","weight":0.207046,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_(biology)"},{"name":"Lymphoma","weight":0.160012,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoma"},{"name":"Therapy","weight":0.0805305,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Food","weight":0.0370044,"wikipedia_article":"http://en.wikipedia.org/wiki/Food"},{"name":"Mantle cell lymphoma","weight":0.0342852,"wikipedia_article":"http://en.wikipedia.org/wiki/Mantle_cell_lymphoma"},{"name":"Medial collateral ligament","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Medial_collateral_ligament"},{"name":"Lyndon B. Johnson","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Lyndon_B._Johnson"},{"name":"Mantle (geology)","weight":0.0148276,"wikipedia_article":"http://en.wikipedia.org/wiki/Mantle_(geology)"}]}
